Neuromodulation therapy sheds light on intractable neurological diseases

Background
  Progressive or drug-resistant cases with epilepsy, Parkinson's disease, dystonia and intractable pain are severely restricted not only in healthy but in social lives. Neuromodulation therapy (NM therapy) consists of electrical stimulation to the brain and spinal cord to modulate neural excitation/inhibition with consequent improvement of neurological symptoms and ADL/QOL.

Purpose of the activity
・ Face each patient and provide optimal treatment.
・ Conduct high-quality basic and clinical research on NM therapy.

Outline of activity
  We actively introduce NM therapy for patients who are refractory to drug treatment. We are working to maintain the patient's ADL and QOL by fine stimulation adjustments. Additionally, basic researches on NM therapy is ongoing with subsequent clinical researches originated from Okayama University.

Future perspectives
・Medical-industry collaboration through NM therapy
・Comprehensive team medical practice
 

DBS surgery

SCS

Representative

Search by
Free Word

Example

Search by
Theme
Search by
SDGs
Search by
Department
Search by
Representative